Recombinant CCN2 (Pamrevlumab Biosimilar) anticorps
Research Grade
Reactivité: Humain
ELISA, WB
Hôte: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits CCN2 (Pamrevlumab Biosimilar)
- CCN2 (Pamrevlumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Human
- Expression System
- Mammalian cells
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp CCN2 (Pamrevlumab Biosimilar) est non-conjugé
- Application
- ELISA, Western Blotting (WB)
- Fonction
- Pamrevlumab Biosimilar - Anti-CTGF, IGFBP-8 mAb - Research Grade
- Attributs du produit
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Pureté
- > 85%
- Classe de qualité
- Research Grade
- Isotype
- IgG1 kappa
-
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer PH7.5
- Stock
- -80 °C
- Stockage commentaire
- store at -80°C
-
- Antigène
- CCN2 (Pamrevlumab Biosimilar)
- Abstract
- CCN2 (Pamrevlumab Biosimilar) Produits
- Sujet
- Pamrevlumab is a recombinant human antibody that binds to connective tissue growth factor (CTGF). It can be used for the research of idiopathic pulmonary fibrosis (IPF).
- Numéro CAS
- 946415-13-0
-
Vous êtes ici:
